EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detection of High-Risk Human Papillomavirus (HPV), p16 and EGFR in Lung Cancer: Insights from the Mediterranean Region of Turkey

Arsenal Sezgin Alikanoğlu, İrem Atalay Karaçay

Viruses · 2024

DOI: 10.3390/v16081201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Arsenal Sezgin Alikanoğlu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Antalya Education and Research Hospital, Health Sciences University, Antalya 07100, Turkey. Hauptthemen laut MEDLINE: Lung Neoplasms, Papillomavirus Infections, Cyclin-Dependent Kinase Inhibitor p16, Papillomaviridae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV) is an oncogenic DNA virus that plays a role in different cancer types. The aim of this study was to detect the prevalence and types of HPV and its relation with p16, EGFR and clinical findings in lung cancer. HPV and EGFR detection and genotyping of HPV were performed by polymerase chain reaction (PCR) and p16 by immunohistochemistry. Fifty lung cancer patients and seven patients with non-neoplastic lung disease were enrolled in this study. HPV was positive in 78% (39/50) of lung cancer cases. HPV 51 was the most frequent type, followed by HPV 16. Moreover, p16 was positive in 24% (12/50) of the cancer patients, and all of these patients were HPV-positive, while 27 HPV-positive patients showed no p16 expression. There was no relationship between HPV infection and p16 (p = 0.05), gender (p = 0.42), age (p = 0.38), or smoking history (p = 0.68). Although not statistically significant, the HPV prevalence was found to be higher in cancer patients compared to non-neoplastic patients. The prevalence of HPV in lung cancer varies across different studies, which may be due to differences in the detection methods, number of patients, geographic regions, and vaccination status. Further studies are necessary to understand the role of HPV in lung cancer pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPapillomavirus InfectionsCyclin-Dependent Kinase Inhibitor p16PapillomaviridaeErbB ReceptorsHumansFemaleMaleMiddle AgedAgedTurkeyPrevalenceMediterranean RegionAdultGenotypeDNA, ViralAged, 80 and overHuman Papillomavirus Viruses

Stichwörter der Autor:innen

human papillomavirus (HPV)lung cancerp16 proteinpolymerase chain reaction (PCR)viral oncology

Substanzen

Cyclin-Dependent Kinase Inhibitor p16ErbB ReceptorsEGFR protein, humanCDKN2A protein, humanDNA, Viral

Autor:innen und Institutionen

  • Pathology Department, Antalya Education and Research Hospital, Health Sciences University, Antalya 07100, Turkey.
  • Pathology Department, Alanya Alaaddin Keykubat University, Antalya 07400, Turkey.

Zitieren

APA

Alikanoğlu, A. S., & Karaçay, İ. A. (2024). Detection of High-Risk Human Papillomavirus (HPV), p16 and EGFR in Lung Cancer: Insights from the Mediterranean Region of Turkey. Viruses. https://doi.org/10.3390/v16081201

Vancouver

Alikanoğlu AS, Karaçay İA. Detection of High-Risk Human Papillomavirus (HPV), p16 and EGFR in Lung Cancer: Insights from the Mediterranean Region of Turkey. Viruses. 2024. doi:10.3390/v16081201

BibTeX
@article{Alikanolu2024,
  author = {Alikanoğlu, Arsenal Sezgin and Karaçay, İrem Atalay},
  title = {Detection of High-Risk Human Papillomavirus (HPV), p16 and EGFR in Lung Cancer: Insights from the Mediterranean Region of Turkey},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16081201}
}
Kostenlos starten →